Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
NEW YORK (AP) — The stock market is capping a rough month. A slowdown in the economy and corporate earnings weighed on investors. The S&P 500 fell 3 percent in January, its worse monthly performance in a year. Today, the 500 index dipped 26 points, or 1.3 percent, to 1,994. The Dow slumped 252 points, or 1.5 percent, to close at 17,164. The Nasdaq eased 48 points, or 1 percent, to 4,635.
NEW YORK (AP) — The price of oil is up 7 percent on indications that production in the U.S. has slowed following the big drop in prices since last June. Benchmark U.S. crude surged $3.71 to $ 48.24 a barrel today in New York. And Brent crude rose $3.86 to close at $52.99 in London. The price of oil plummeted about 60 percent since June as global supplies grew faster than demand.
NEW YORK (AP) — Consumers may see improved networks after AT&T and Verizon, the two largest U.S. wireless companies, spent billions in the government's latest airwaves auction. The new spectrum will allow wireless companies to offer more capacity for mobile data services, helping ease congested networks. The auction is raising $41.3 billion for the federal government.
IRVING, Texas (AP) — Exxon Mobil is updating its corporate policies to protect employees from discrimination for sexual orientation or gender identity. A spokesman says the oil giant added these protections to comply with federal law. In July, President Barack Obama signed an executive order that expanded protections for gay and transgender employees of federal contractors.
WASHINGTON (AP) — Federal health regulators are approving an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. The Food and Drug Administration first approved Shire PLC's Vyvanse as a once-a-day pill for attention deficit hyperactivity disorder in 2007. Today, the agency cleared the drug for adults who compulsively overeat.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
